Nouvelles Eulerpool AB Science

Eulerpool-AFX AB Science

AB Science Actualités des actions

AB Science est surveillé par de nombreux journalistes et investisseurs du monde entier. Nous regroupons ici les dernières actualités AB Science.

• 31 mai ·

  Yahoo
  AB Science is providing a summary of the live webcast held on May 30, 2024, giving an update on the application for conditional marketing authorization of masitinib in ALS
• 29 mai ·

  Yahoo
  AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS
• 15 mai ·

  Yahoo
  AB Science reports its revenues for the year 2023 and provides an update on its activities
• 13 mai ·

  Yahoo
  AB Science announces issuance of a European patent for masitinib in the treatment of severe mastocytosis with protection until 2036
• 7 mai ·

  Yahoo
  AB Science : A new publication in the medical journal Muscle & Nerve validates the use of the rate of decline of ALSFR-S score (ΔFS) for the design of clinical studies and the treatment choice for amyotrophic lateral sclerosis (ALS) patient
• 2 mai ·

  Yahoo
  AB Science : The Paris Court of Appeal confirms the acquittal of the CEO of AB Science, Alain Moussy, and reduces the amount of the financial penalty imposed on AB Science
• 30 avril ·

  Yahoo
  AB Science announces a slight delay in the publication of its 2023 annual financial report
• 3 avril ·

  Yahoo
  AB Science announces that Health Canada has granted eligibility for reconsideration request for masitinib in ALS
• 13 mars ·

  Yahoo
  AB Science: New research shows that masitinib limits neuronal damage in a model of neuroimmune-driven neurodegenerative disease
• 7 mars ·

  Yahoo
  AB Science provides a summary of the live webcast held on March 4, 2024 giving an update on AB Science development